Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels
- PMID: 1379922
Nucleolar organizer regions in prostatic adenocarcinomas. Comparison with flow cytometric analysis, tumor grade, stage and serum prostate-specific antigen levels
Abstract
Twenty-eight cases of prostatic adenocarcinomas have been selected and the mean argyrophil nucleolar organizer region (AgNOR) count for each case was evaluated. Nine of these tumors were of high, 13 of median and 6 of low differentiation. It was found that as the tumors became less differentiated, the AgNOR count increased (p less than 0.001). Stage of the disease, serum prostate-specific antigen (PSA) value, and DNA ploidy of all these cases have been examined as well but no statistically significant correlation among these three parameters and the AgNOR count was found.
Similar articles
-
Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.Croat Med J. 2000 Jun;41(2):154-8. Croat Med J. 2000. PMID: 10853043
-
[Nucleolus organizer regions and ploidy pattern of DNA in stomach neoplasms].Rev Med Chil. 1991 Jun;119(6):647-51. Rev Med Chil. 1991. PMID: 1844368 Spanish.
-
[Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].Pathologica. 1992 Jan-Feb;84(1089):49-55. Pathologica. 1992. PMID: 1379709 Italian.
-
Prostate cancer-associated markers.Immunol Ser. 1990;53:339-56. Immunol Ser. 1990. PMID: 1713065 Review.
-
The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate.Mo Med. 1991 Jun;88(6):349-52. Mo Med. 1991. PMID: 1712422 Review.
Cited by
-
Nucleolar organizer regions in low- and high-grade carcinomas of the prostate.World J Urol. 1995;13(3):195-9. doi: 10.1007/BF00184879. World J Urol. 1995. PMID: 7550395
-
AgNOR quantity in needle biopsy specimens of prostatic adenocarcinomas: correlation with proliferation state, Gleason score, clinical stage, and DNA content.Clin Mol Pathol. 1996 Aug;49(4):M209-13. doi: 10.1136/mp.49.4.m209. Clin Mol Pathol. 1996. PMID: 16696076 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous